ArticleMolecular therapy. Oncology2026

Suppression of PARP1 enhances PTEN mRNA therapy in castration-resistant prostate cancer by glycolysis disruption.

Bo Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.